Literature DB >> 24439480

Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.

Scott P Allen1, Sandeep Rajan1, Lynn Duffy1, Heather Mortiboys1, Adrian Higginbottom1, Andrew J Grierson1, Pamela J Shaw2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder involving the progressive degeneration of motor neurons in the brain and spinal cord. Mitochondrial dysfunction plays a key role in ALS disease progression and has been observed in several ALS cellular and animal models. Here, we show that fibroblasts isolated from ALS cases with a Cu/Zn superoxide dismutase (SOD1) I113T mutation recapitulate these mitochondrial defects. Using a novel technique, which measures mitochondrial respiration and glycolytic flux simultaneously in living cells, we have shown that SOD1 mutation causes a reduction in mitochondrial respiration and an increase in glycolytic flux. This causes a reduction in adenosine triphosphate produced by oxidative phosphorylation and an increase in adenosine triphosphate produced by glycolysis. Switching the energy source from glucose to galactose caused uncoupling of mitochondria with increased proton leak in SOD1(I113T) fibroblasts. Assessment of the contribution of fatty acid oxidation to total respiration, suggested that fatty acid oxidation is reduced in SOD1 ALS fibroblasts, an effect which can be mimicked by starving the control cells of glucose. These results highlight the importance of understanding the interplay between the major metabolic pathways, which has the potential to lead to strategies to correct the metabolic dysregulation observed in ALS cases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; Metabolism; Mitochondria; SOD1

Mesh:

Substances:

Year:  2013        PMID: 24439480     DOI: 10.1016/j.neurobiolaging.2013.11.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  28 in total

1.  Superoxide dismutase 1 is positively selected to minimize protein aggregation in great apes.

Authors:  Pouria Dasmeh; Kasper P Kepp
Journal:  Cell Mol Life Sci       Date:  2017-04-07       Impact factor: 9.261

Review 2.  Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.

Authors:  Andrew T Nelson; Davide Trotti
Journal:  Neurotherapeutics       Date:  2022-06-30       Impact factor: 6.088

3.  Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints.

Authors:  Teresa Cunha-Oliveira; Marcelo Carvalho; Vilma Sardão; Elisabete Ferreiro; Débora Mena; Francisco B Pereira; Fernanda Borges; Paulo J Oliveira; Filomena S G Silva
Journal:  Mol Neurobiol       Date:  2022-08-06       Impact factor: 5.682

Review 4.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

5.  Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-19       Impact factor: 6.200

6.  Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.

Authors:  Kathryne Kirk; Chris Gennings; Jonathan C Hupf; Saba Tadesse; Marilena D'Aurelio; Hibiki Kawamata; Federica Valsecchi; Hiroshi Mitsumoto; Giovanni Manfredi
Journal:  Ann Neurol       Date:  2014-08-21       Impact factor: 10.422

7.  C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.

Authors:  Scott P Allen; Benjamin Hall; Ryan Woof; Laura Francis; Noemi Gatto; Allan C Shaw; Monika Myszczynska; Jordan Hemingway; Ian Coldicott; Amelia Willcock; Lucy Job; Rachel M Hughes; Camilla Boschian; Nadhim Bayatti; Paul R Heath; Oliver Bandmann; Heather Mortiboys; Laura Ferraiuolo; Pamela J Shaw
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

8.  Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions.

Authors:  Rohini Raman; Scott P Allen; Emily F Goodall; Shelley Kramer; Lize-Linde Ponger; Paul R Heath; Marta Milo; Hannah C Hollinger; Theresa Walsh; J Robin Highley; Simon Olpin; Christopher J McDermott; Pamela J Shaw; Janine Kirby
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

9.  SOD-1 Variants in Amyotrophic Lateral Sclerosis: Systematic Re-Evaluation According to ACMG-AMP Guidelines.

Authors:  Paola Ruffo; Benedetta Perrone; Francesca Luisa Conforti
Journal:  Genes (Basel)       Date:  2022-03-18       Impact factor: 4.096

10.  Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts.

Authors:  Margarita Gerou; Benjamin Hall; Ryan Woof; Jessica Allsop; Stephen J Kolb; Kathrin Meyer; Pamela J Shaw; Scott P Allen
Journal:  Neurobiol Aging       Date:  2021-04-27       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.